Clinical Trials Directory

Trials / Sponsors / Cooperative Study Group A for Hematology

Cooperative Study Group A for Hematology

Network · 18 registered clinical trials.

StatusTrialPhaseStarted
UnknownCyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)
Myelodysplastic Syndrome
—2010-11-01
UnknownReduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Myelodysplastic Syndrome
—2010-11-01
UnknownHelicobacter Pylori Immune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
—2010-09-01
UnknownIdarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)
Acute Myelogenous Leukemia
Phase 32010-05-01
UnknownComparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
Aplastic Anemia
Phase 32010-03-01
UnknownEfficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory
Thrombocytopenia
Phase 22010-02-01
UnknownAutologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in th
Acute Myeloid Leukemia
Phase 22010-01-01
UnknownBiweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
Lymphoma
Phase 22006-11-01
CompletedTwo Cycles of PAD Combination by AHCT in MM
Multiple Myeloma
Phase 22006-07-01
UnknownA Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Acute Lymphoblastic Leukemia
Phase 22006-06-01
CompletedHigh Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
Idiopathic Thrombocytopenic Purpura
Phase 32005-09-01
UnknownFludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
Acute Myeloid Leukemia
Phase 22004-12-01
UnknownFLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
Acute Myeloid Leukemia
Phase 22004-12-01
CompletedConditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
HEMATOLOGIC MALIGNANCIES
—2003-12-01
CompletedComparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT
Bone Marrow Failure Syndromes
Phase 32003-03-01
CompletedBusulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
Leukemia, Myelodysplastic Syndrome
Phase 32002-05-01
CompletedHigh Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
ACUTE MYELOGENOUS LEUKEMIA
Phase 32001-08-01
CompletedUsing Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
Chronic Lymphocytic Leukemia, Lymphoma, Multiple Myeloma
Phase 22001-07-01